Your browser doesn't support javascript.
loading
Evaluation of the Effects of Repeat-Dose Dabrafenib on the Single-Dose Pharmacokinetics of Rosuvastatin (OATP1B1/1B3 Substrate) and Midazolam (CYP3A4 Substrate).
Nebot, Noelia; Won, Christina S; Moreno, Victor; Muñoz-Couselo, Eva; Lee, Dung-Yang; Gasal, Eduard; Bouillaud, Emmanuel.
Afiliação
  • Nebot N; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Won CS; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA.
  • Moreno V; START Madrid-FJD, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
  • Muñoz-Couselo E; VHIO - Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Lee DY; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Gasal E; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Bouillaud E; Novartis Pharma AG, Basel, Switzerland.
Clin Pharmacol Drug Dev ; 10(9): 1054-1063, 2021 09.
Article em En | MEDLINE | ID: mdl-33932130
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oximas / Midazolam / Rosuvastatina Cálcica / Imidazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oximas / Midazolam / Rosuvastatina Cálcica / Imidazóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article